Pure Global AI
CDSCO UID IMP/IVD/2023/000036_f1fc63ba636a39df34aa908268693d6d_de33f165e9ace27a3837082accdc4a2c

Immunoassay Controls

SNIBE DIAGNOSTIC (India) Private Limited.Device Class Class BIndia CDSCOBrand: MAGLUMI® Tip
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2023/000036_f1fc63ba636a39df34aa908268693d6d_de33f165e9ace27a3837082accdc4a2c
Device class
Class B
Brand name
MAGLUMI® Tip
Approving authority
CDSCO
Product information
The Immunoassay Controls are intended for performing quality control procedures with MAGLUMI chemiluminescence immunoassay (MAGLUMI® Tip) assays when used for the quantitative determination of Total T3, Total T4, Free T3, Free T4, TSH, FSH, LH, Prolactin, Progesterone, Estradiol, Testosterone, Total HCG, Insulin and C-Peptide in human serum or plasma
About this record

Immunoassay Controls is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_f1fc63ba636a39df34aa908268693d6d_de33f165e9ace27a3837082accdc4a2c. This device is marketed under the brand name MAGLUMI® Tip. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.